"The Cardinal Bernardin Cancer Center brings together specialists to provide the expertise and compassionate care needed to diagnose and treat cancer."

During the past decade, Cardinal Bernardin Cancer Center at Loyola University Medical Center conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 60 clinical trials were completed, i.e. on average, 461.5% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 12 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cardinal Bernardin Cancer Center at Loyola University Medical Center" #1 sponsor was "SWOG Cancer Research Network" with 69 trials, followed by "Alliance for Clinical Trials in Oncology" with 15 trials sponsored, "Radiation Therapy Oncology Group" with 14 trials sponsored, "Seagen Inc." with 13 trials sponsored and "Loyola University" with 13 trials sponsored. Other sponsors include 48 different institutions and companies that sponsored additional 33 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cardinal Bernardin Cancer Center at Loyola University Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 123 trials as a collaborator, "Cancer and Leukemia Group B" with 12 trials as a collaborator, "NCIC Clinical Trials Group" with 10 trials as a collaborator, "Eastern Cooperative Oncology Group" with 9 trials as a collaborator and "NRG Oncology" with 9 trials as a collaborator. Other collaborators include 56 different institutions and companies that were collaborators in the rest 40 trials.

According to Clinical.Site data, the most researched conditions in "Cardinal Bernardin Cancer Center at Loyola University Medical Center" are "Breast Cancer" (25 trials), "Leukemia" (17 trials), "Lung Cancer" (16 trials), "Lymphoma" (16 trials) and "Prostate Cancer" (10 trials). Many other conditions were trialed in "Cardinal Bernardin Cancer Center at Loyola University Medical Center" in a lesser frequency.

Most popular intervention types in "Cardinal Bernardin Cancer Center at Loyola University Medical Center" are "Drug" (145 trials), "Radiation" (40 trials), "Biological" (36 trials), "Procedure" (25 trials) and "Other" (22 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (25 trials), "cyclophosphamide" (23 trials), "cisplatin" (18 trials), "prednisone" (14 trials) and "etoposide" (12 trials). Other intervention names were less common.

The vast majority of trials in "Cardinal Bernardin Cancer Center at Loyola University Medical Center" are 133 trials for "All" genders, 28 trials for "Female" genders and 11 trials for "Male" genders.

Currently, there are NaN active trials in "Cardinal Bernardin Cancer Center at Loyola University Medical Center". undefined are not yet recruiting, 2 are recruiting, 17 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 125 completed trials in Cardinal Bernardin Cancer Center at Loyola University Medical Center, undefined suspended trials, and 19 terminated clinical trials to date.

Out of the total trials that were conducted in Cardinal Bernardin Cancer Center at Loyola University Medical Center, 15 "Phase 1" clinical trials were conducted, 81 "Phase 2" clinical trials and 66 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 5 trials that are defined as “Not Applicable".